Details of Drug

Details of Drug

 Drug General Information (ID: D1780)
  Drug Name
Emicizumab
  Drug Type Monoclonal antibody
  Drug Synonymous
7NL2E3F6K3; 1610943-06-0; UNII-7NL2E3F6K3; Emicizumab; Emicizumab [INN]; Immunoglobulin G4-kappa, bispecific, anti-(homo sapiens F9a (activated coagulation factor F9, activated coagulation factor IX) and anti-(homo sapiens F10 (coagulation factor 10, coagulation factor X)), humanized monoclonal antibody; Hemlibra; Emicizumab-kxwh
    Click to Show/Hide
  Disease Class 3B10: Coagulation defect
  Therapeutic Class Coagulation Modifiers
  External Link
TTD ID D09XTN

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
BM047  Additive thrombogenic effects
  Relation Graph
 Full list of drugs interacting with Emicizumab
      Pharmacodynamic additive effects
   Additive thrombogenic effects Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1740
 
Anti-inhibitor coagulant complex
 
NA
 
NA
Major    Inter Info   
[1]
References
1 Product Information. Hemlibra (emicizumab). Genentech, South San Francisco, CA.